Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

By sjmartinez • September 1, 2024

Sciurba FC, Christenson SA, Rheault T, Bengtsson T, Rickard K, Barjaktarevic IZ. Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine Reduces Exacerbation Rate and Risk in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease. Chest. 2024 Aug 26:S0012-3692(24)04937-7. doi: 10.1016/j.chest.2024.07.168. Epub ahead of print. PMID: 39197510.

Tags: chronic obstructive pulmonary disorder, ensifentrine, exacerbation, patient-reported outcomes, Publications, Pulmonary, Critical Care & Sleep Medicine

Pediatric Approach to Trauma, Treatment, and Resilience (PATTeR) for Trainees: A Standardized Trauma-Informed Care Training for Pediatric Residents

Thang CK, Kucaj S, Arellano F, Lay K, Wilhalme H, Szilagyi M. Pediatric Approach to Trauma, Treatment, and Resilience (PATTeR) for Trainees: A Standardized Trauma-Informed[...]

Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and nonmyogenic pathways

Aguiari P, Villani V, Liu YY, Carraro G, Brent GA, Perin L, Milanesi A. Hypothyroidism impairs skeletal muscle regeneration after injury by altering myogenic and[...]

On Mentoring

Weisman MH. On Mentoring. Arthritis Care Res (Hoboken). 2026 Mar 23. doi: 10.1002/acr.80045. Epub ahead of print. PMID: 41869975.